U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: January 5 - 11, 2025
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: January 5 - 11, 2025

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 01/11/2025
Location: San Francisco, CA
Subject: Longwood Healthcare Leaders San Francisco CEO; Panelist Regulatory Roundtable
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, government, academia, and other invited attendees

Official Name: Jim Jones, Deputy Commissioner for Human Foods

No Significant Event

Official Name: Kimberlee Trzeciak, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Angelique Hebert, Acting Deputy Commissioner for Operations

No Significant Event

Official Name: Michael Rogers, Associate Commissioner for Inspections and Investigations

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 01/07/2025
Location: Virtual
Subject: National Foundation for Infectious Diseases - COVID-19 Updates and Best Practices Webinar: COVID-19 Vaccine Updates
FDA Participant/Group: N/A
Non FDA Participant/Group: Healthcare and public stakeholders

Event Date: 01/08/2025
Location: Washington, DC
Subject: White House Cell and Gene Therapy Forum: Federal Spotlight - A Regulatory Approach to Accelerating Innovation
FDA Participant/Group: NICOLE VERDUN; 
Non FDA Participant/Group: Industry, research, academic, healthcare, patient advocacy, and government stakeholders

Event Date: 01/11/2025
Location: Virtual
Subject: Longwood Healthcare Leaders San Francisco CEO; Fireside Chat
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, government, academia, and other invited attendees

Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

Back to Top